SK47098A3 - Urogenital carcinoma tlp complex peptides and antibodies thereof - Google Patents
Urogenital carcinoma tlp complex peptides and antibodies thereof Download PDFInfo
- Publication number
- SK47098A3 SK47098A3 SK470-98A SK47098A SK47098A3 SK 47098 A3 SK47098 A3 SK 47098A3 SK 47098 A SK47098 A SK 47098A SK 47098 A3 SK47098 A3 SK 47098A3
- Authority
- SK
- Slovakia
- Prior art keywords
- tlp
- peptide
- seq
- amino acid
- sequence
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 19
- 201000009030 Carcinoma Diseases 0.000 title claims abstract description 10
- 102000004196 processed proteins & peptides Human genes 0.000 title claims description 8
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 3
- 150000001413 amino acids Chemical group 0.000 claims description 8
- 206010028980 Neoplasm Diseases 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 238000009007 Diagnostic Kit Methods 0.000 claims description 2
- OOCFXNOVSLSHAB-IUCAKERBSA-N Gly-Pro-Pro Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 OOCFXNOVSLSHAB-IUCAKERBSA-N 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- 210000004392 genitalia Anatomy 0.000 claims description 2
- 108010070643 prolylglutamic acid Proteins 0.000 claims description 2
- 238000001114 immunoprecipitation Methods 0.000 claims 2
- 210000002966 serum Anatomy 0.000 claims 2
- AKJRHDMTEJXTPV-ACZMJKKPSA-N Glu-Asn-Ala Chemical compound C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(O)=O)C(O)=O AKJRHDMTEJXTPV-ACZMJKKPSA-N 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 239000000835 fiber Substances 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 208000024313 Testicular Neoplasms Diseases 0.000 description 4
- 206010057644 Testis cancer Diseases 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 201000003120 testicular cancer Diseases 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- 210000001635 urinary tract Anatomy 0.000 description 3
- 206010001197 Adenocarcinoma of the cervix Diseases 0.000 description 2
- 208000034246 Adenocarcinoma of the cervix uteri Diseases 0.000 description 2
- 206010038486 Renal neoplasms Diseases 0.000 description 2
- 201000006662 cervical adenocarcinoma Diseases 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000009826 neoplastic cell growth Effects 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- SWLOHUMCUDRTCL-ZLUOBGJFSA-N Asn-Ala-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N SWLOHUMCUDRTCL-ZLUOBGJFSA-N 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- YQPFCZVKMUVZIN-AUTRQRHGSA-N Glu-Val-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O YQPFCZVKMUVZIN-AUTRQRHGSA-N 0.000 description 1
- 102000007474 Multiprotein Complexes Human genes 0.000 description 1
- 108010085220 Multiprotein Complexes Proteins 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 208000037841 lung tumor Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000734 protein sequencing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT96RM000496A IT1284870B1 (it) | 1996-07-10 | 1996-07-10 | Peptidi dei complessi tlp da carcinomi dell'apparato urogenitale e anticorpi diretti contro di essi |
| PCT/IT1997/000158 WO1998001462A2 (en) | 1996-07-10 | 1997-07-02 | Urogenital carcinoma tlp complex peptides and antibodies thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK47098A3 true SK47098A3 (en) | 1999-02-11 |
Family
ID=11404336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK470-98A SK47098A3 (en) | 1996-07-10 | 1997-07-02 | Urogenital carcinoma tlp complex peptides and antibodies thereof |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US6222010B1 (es) |
| EP (1) | EP0851872B1 (es) |
| CN (1) | CN1136230C (es) |
| AT (1) | ATE200678T1 (es) |
| AU (1) | AU716721B2 (es) |
| CA (1) | CA2234151C (es) |
| DE (1) | DE69704606T2 (es) |
| DK (1) | DK0851872T3 (es) |
| ES (1) | ES2156393T3 (es) |
| GR (1) | GR3036057T3 (es) |
| IT (1) | IT1284870B1 (es) |
| NO (1) | NO982227D0 (es) |
| PT (1) | PT851872E (es) |
| RU (1) | RU2203679C2 (es) |
| SK (1) | SK47098A3 (es) |
| WO (1) | WO1998001462A2 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1284870B1 (it) | 1996-07-10 | 1998-05-22 | Ist Farmacoterapico It Spa | Peptidi dei complessi tlp da carcinomi dell'apparato urogenitale e anticorpi diretti contro di essi |
| DE10001717C1 (de) * | 2000-01-18 | 2001-04-26 | Xcellsis Gmbh | Brennstoffzellensystem |
| ITMI20011380A1 (it) * | 2001-06-29 | 2002-12-29 | Unihart Corp | Antigene tlp e sue applicazioni diagnostiche |
| CN101712946B (zh) * | 2009-09-27 | 2013-02-27 | 南通大学附属医院 | 构建生殖结节器官培养尿道体外发育模型的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4270924A (en) * | 1979-04-10 | 1981-06-02 | Crooke Stanley T | Diagnostic method for detecting cancer |
| IT1206250B (it) | 1987-02-18 | 1989-04-14 | Ist Farmacoterapico It Spa | Stiche umane e relativi prodotti metodo per l'estrazione di antigeni di membrana aventi proprieta' immunogene a partire da cellule neopla- |
| RU2009500C1 (ru) * | 1987-03-11 | 1994-03-15 | Фармиталиа Карло Эрба С.Р.Л. | Способ получения цитотоксического коньюгата |
| IT1262954B (it) | 1992-07-03 | 1996-07-23 | Ist Farmacoterapico It Spa | Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi. |
| IT1284870B1 (it) | 1996-07-10 | 1998-05-22 | Ist Farmacoterapico It Spa | Peptidi dei complessi tlp da carcinomi dell'apparato urogenitale e anticorpi diretti contro di essi |
-
1996
- 1996-07-10 IT IT96RM000496A patent/IT1284870B1/it active IP Right Grant
-
1997
- 1997-07-02 CN CNB971912130A patent/CN1136230C/zh not_active Expired - Fee Related
- 1997-07-02 ES ES97932002T patent/ES2156393T3/es not_active Expired - Lifetime
- 1997-07-02 SK SK470-98A patent/SK47098A3/sk unknown
- 1997-07-02 RU RU98106385/14A patent/RU2203679C2/ru not_active IP Right Cessation
- 1997-07-02 DE DE69704606T patent/DE69704606T2/de not_active Expired - Fee Related
- 1997-07-02 EP EP97932002A patent/EP0851872B1/en not_active Expired - Lifetime
- 1997-07-02 WO PCT/IT1997/000158 patent/WO1998001462A2/en not_active Ceased
- 1997-07-02 AT AT97932002T patent/ATE200678T1/de not_active IP Right Cessation
- 1997-07-02 AU AU35572/97A patent/AU716721B2/en not_active Ceased
- 1997-07-02 DK DK97932002T patent/DK0851872T3/da active
- 1997-07-02 US US09/051,357 patent/US6222010B1/en not_active Expired - Fee Related
- 1997-07-02 PT PT97932002T patent/PT851872E/pt unknown
- 1997-07-02 CA CA002234151A patent/CA2234151C/en not_active Expired - Fee Related
-
1998
- 1998-05-15 NO NO982227A patent/NO982227D0/no unknown
-
2000
- 2000-02-15 US US09/504,089 patent/US20030170750A1/en not_active Abandoned
- 2000-09-14 US US09/661,503 patent/US6664378B1/en not_active Expired - Fee Related
-
2001
- 2001-06-14 GR GR20010400899T patent/GR3036057T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US20030170750A1 (en) | 2003-09-11 |
| AU3557297A (en) | 1998-02-02 |
| DE69704606D1 (de) | 2001-05-23 |
| CN1205012A (zh) | 1999-01-13 |
| US6664378B1 (en) | 2003-12-16 |
| WO1998001462A3 (en) | 1998-08-06 |
| CN1136230C (zh) | 2004-01-28 |
| DK0851872T3 (da) | 2001-06-18 |
| ITRM960496A1 (it) | 1998-01-10 |
| ITRM960496A0 (es) | 1996-07-10 |
| CA2234151A1 (en) | 1998-01-15 |
| DE69704606T2 (de) | 2001-11-08 |
| EP0851872A3 (en) | 1998-10-14 |
| NO982227L (no) | 1998-05-15 |
| ES2156393T3 (es) | 2001-06-16 |
| NO982227D0 (no) | 1998-05-15 |
| US6222010B1 (en) | 2001-04-24 |
| PT851872E (pt) | 2001-08-30 |
| WO1998001462A2 (en) | 1998-01-15 |
| ATE200678T1 (de) | 2001-05-15 |
| EP0851872A2 (en) | 1998-07-08 |
| RU2203679C2 (ru) | 2003-05-10 |
| CA2234151C (en) | 2004-02-03 |
| GR3036057T3 (en) | 2001-09-28 |
| AU716721B2 (en) | 2000-03-02 |
| EP0851872B1 (en) | 2001-04-18 |
| IT1284870B1 (it) | 1998-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH08503490A (ja) | リポ多糖結合性および中和能のあるペプチド | |
| CA2476835A1 (en) | A non-invasive diagnostic test utilizing histone modification markers | |
| Liu et al. | Isolation of human salivary mucin MG2 by a novel method and characterization of its interactions with oral bacteria | |
| US4196186A (en) | Method for diagnosing malignant gliol brain tumors | |
| KR20000010561A (ko) | 항원 특이적 면역억제 요법에 사용하기에 적합한 신규 펩티드 | |
| JPS62115291A (ja) | インタ−フエロン誘起遺伝子及び酵素 | |
| JOUBERT | Snake Venom Toxins: The Amino‐Acid Sequences of Three Toxins (CM‐8, CM‐11 and CM‐13a) from Naja haje annulifera (Egyptian cobra) Venom | |
| EP0649433B1 (en) | Antigenic regions of tumour-liberated particles (tlp) complexes and antibodies against them | |
| US4624932A (en) | Recognins and their chemoreciprocals | |
| SK47098A3 (en) | Urogenital carcinoma tlp complex peptides and antibodies thereof | |
| CN115724917A (zh) | 靶向pd-1的多肽-protac及其应用 | |
| DE69106141T2 (de) | Non-a non-b sequenzen. | |
| JPH083486B2 (ja) | 体液中の基底膜コラーゲンの測定法及び基底膜コラーゲン―ドメインnc1に対する抗体の検出法 | |
| JPH01501518A (ja) | N‐mycタンパク質のためのアッセイ及び抗体 | |
| AU624071B2 (en) | General cancer-associated scm-recognition factor, preparation and method of use | |
| Skinner et al. | N-terminal amino acid analysis of the amyloid fibril protein | |
| EP0407451A1 (en) | General cancer-associated scm-recognition factor, preparation and method of use | |
| US4624931A (en) | Recognins and their chemoreciprocals | |
| Bing et al. | Isolation and characterization of two antigenically active peptides from bovine β-lactoglobulin-A | |
| JPH11503999A (ja) | ヘリコバクター ピロリ抗原 | |
| JP2668726B2 (ja) | 細胞親和性の高い化学修飾ラクトフェリンの調製方法 | |
| JPH02152988A (ja) | ペプチド化合物および該ペプチド化合物を使用して得られる抗血清および抗体 | |
| EP0684957A1 (en) | $i(STREPTOCOCCUS SUIS) ADHESIN PROTEIN AND METHOD FOR PRODUCING IT | |
| JPH0341097A (ja) | 補体系のd因子の調製方法 | |
| CA2233593A1 (en) | Novel protein molecules and uses therefor |